Adjuvant Cemiplimab: New Standard for High-Risk CSCC Recurrence | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
2:05
Adjuvant Cemiplimab: New Standard for High-Risk CSCC Recurrence | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
8 个月之前
targetedonc.com
Dr Nguyen on the Evolving Landscape of Adjuvant Therapy in Localized ccRCC | OncLive
Dr Nguyen on the Evolving Landscape of Adjuvant Therapy in Localized ccRCC | OncLive
11 个月之前
onclive.com
Dr. Wakelee on Explaining Adjuvant Therapy to Patients | OncLive
Dr. Wakelee on Explaining Adjuvant Therapy to Patients | OncLive
2011年9月21日
onclive.com
How Neoadjuvant Therapy Beats Postoperative Chemotherapy
How Neoadjuvant Therapy Beats Postoperative Chemotherapy
2025年1月28日
medscape.com
Dr. Marshall on Changes With Adjuvant Treatment in CRC | OncLive
Dr. Marshall on Changes With Adjuvant Treatment in CRC | OncLive
2021年1月25日
onclive.com
Integrating Durvalumab and Atezolizumab Into Neoadjuvant and Adjuvant Sequencing Strategies for Resectable NSCLC | AJMC
Integrating Durvalumab and Atezolizumab Into Neoadjuvant and Adjuvant Sequencing Strategies for Resectable NSCLC | AJMC
2 个月之前
ajmc.com
Adjuvant Therapy in NSCLC: IMPower-010 and KEYNOTE-091 Studies | OncLive
Adjuvant Therapy in NSCLC: IMPower-010 and KEYNOTE-091 Studies | OncLive
2023年7月13日
onclive.com
0:59
Adjuvant Therapy for Treatment of Melanoma
2017年12月28日
curemelanoma.org
2:30
Adjuvant Pembrolizumab Delivers Long-Term Benefits in ccRCC at Increased Risk of Recurrence | OncLive
5 个月之前
onclive.com
Oncology and fight against tumors: adjuvant therapy
2023年2月24日
emergency-live.com
KEYNOTE-091 and IMPOWER010: adjuvant chemotherapy for NSCLC
2022年7月12日
vjoncology.com
Dr. Eng on the Role of Adjuvant Chemotherapy in CRC | OncLive
2020年11月16日
onclive.com
Dr Spigel on Adjuvant Chemotherapy in Stage IA/IIA, Molecularly Higher-Risk NSCLC | OncLive
11 个月之前
onclive.com
Adjuvant vs Neoadjuvant Therapy in NSCLC: Which Approach Offers the Best Chance for Cure?
7 个月之前
medscape.com
IMpower010 and KEYNOTE-091: Adjuvant Immunotherapy in NSCLC | CancerNetwork
2022年5月13日
cancernetwork.com
New Adjuvant Option Emerges for Node-Positive ER Breast Cancer
1 个月前
medscape.com
Why Adjuvant Checkpoint Inhibitors Are Missing the Mark
2 周前
medscape.com
12:49
ALINA: Efficacy and Safety of Adjuvant Alectinib Versus Chemotherapy in Patients With Early-Stage ALK NSCLC | OncLive
2023年11月17日
onclive.com
Neoadjuvant Therapy in NSCLC: 5-Year Study Unveils Nivolumab’s Curative Potential
7 个月之前
medscape.com
AEGEAN: A Phase 3 Trial of Neoadjuvant Durvalumab Chemotherapy Followed by Adjuvant Durvalumab in Patients with Resectable NSCLC | OncLive
2023年5月19日
onclive.com
4:01
Adjuvant Pembrolizumab Plus Cisplatin-Based Chemoradiation in Locally Advanced HNSCC: First Results From the Randomized Phase 2b ADRISK Trial
6 个月之前
reachmd.com
IASLC Issues Consensus on Neoadjuvant, Adjuvant Treatments in Non–Small Cell Lung Cancer
2024年8月8日
medscape.com
Adjuvant Therapy for Advanced Melanoma
2 个月之前
medscape.com
Dr Tolaney on Considerations for Adjuvant CDK4/6 Inhibitors in HR /HER2-Negative Breast Cancer | OncLive
2025年3月8日
onclive.com
1:18
Dr Shu on Advances in Adjuvant Therapy For Early-Stage NSCLC | OncLive
2023年12月5日
onclive.com
Chimiothérapie adjuvante et néo-adjuvante : comment mieux la vivre ?
2016年12月26日
chimio-pratique.com
Dr Adkins on the FDA Approval of Pembrolizumab for Neoadjuvant/Adjuvant Treatment in Resectable, Locally Advanced HNSCC | OncLive
11 个月之前
onclive.com
Real-World Data: Adjuvant Therapy for BRAF-Mutated Melanoma
10 个月之前
medscape.com
Ongoing Study of Adjuvant Elacestrant: Phase 3 ELEGANT | Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
10 个月之前
targetedonc.com
Which of the following agents are used in adjuvant therapy?(a) ... | Filo
已浏览 5029 次1 年前
askfilo.com
展开